Words matter to people living with cancer. Here’s how verbal microaggressions affect their mental state
Madhu Neupane Bastola, Hong Kong Polytechnic University, and Margo Louise Turnbull, Hong Kong Polytechnic University…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Terahertz polarimetry detects microscopic tissue changes linked to cancer and burns
Recent advances in electronics and optics have opened new possibilities for terahertz (THz) waves—an invisible…
The leading risk factor for cancer isn’t what you think
Kristen Haase, University of British Columbia, and Shabbir Alibhai, University of Toronto If you were…
ASCO 2025 Special Part 2! S3E5 The Oncology Journal Club
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
Exercise during chemotherapy may help immune cells fight cancer – patients invited to join new trial
Exercising during chemotherapy and before surgery may help the body send more immune cells into…
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a…
ASKHER2 European survey shows perceived risk and fear of disease recurrence affect health behaviours and decision-making in women with early-stage HER2+ breast cancer
Newly published results from the ASKHER2 European survey underscore the crucial need for physicians to…
HPV drives tumour development in rare nasal cancers
Human papillomavirus (HPV) can drive tumour development in some rare sinonasal squamous cell carcinomas (SNSCCs),…
Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy
A new research paper was published in Volume 16 of Oncotarget on May 29, 2025, titled “Durable…
Pancreatic cancer vaccines eliminate disease in preclinical trials
Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer,…